BVMed supports reinforcing the primacy of the Medical Devices Regulation (MDR) as the applicable sectoral legislation for AI medical devices under a sector-first approach within the AI Act framework, ensuring legal clarity and avoiding duplicative horizontal obligations. For further details please see position paper attached.
BVMed - Bundesverband Medizintechnologie e.V.
Industry association · Germany
Counts here are a floor, never a total: they cover the 639 consultation files tracked so far (53,766 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track BVMed in PolicySpeak: request access →
Work at BVMed - Bundesverband Medizintechnologie e.V.? so we know who speaks for it.
Their record over time
BVMed - Bundesverband Medizintechnologie e.V. filed 2 positions between 14 Oct 2025 and 12 Mar 2026, across 1 of the 639 legislative files tracked here, attaching a full position paper 2 times.
What they argued
BVMed supports the EUs digital agenda and the Commissions ambition to promote innovation that benefits patients and healthcare systems, while emphasising the need to simplify and streamline existing legislation to strengthen Europes competitiveness. Medical technologies already operate under the robust MDR framework, which provides comprehensive requirements for safety, performance, and conformity assessment.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put BVMed - Bundesverband Medizintechnologie e.V. next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from BVMed - Bundesverband Medizintechnologie e.V.’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.